Výsledky vyhledávání - "A Schaefer-Schuler"

Akademický článek

Outstanding increase in tumor-to-background ratio over time allows tumor localization by [89Zr]Zr-PSMA-617 PET/CT in early biochemical recurrence of prostate cancer

Autor: Caroline Burgard, Florian Rosar, Elena Larsen, Fadi Khreish, Johannes Linxweiler, Robert J. Marlowe, Andrea Schaefer-Schuler, Stephan Maus, Sven Petto, Mark Bartholomä, Samer Ezziddin

Publikováno v: Cancer Imaging, Vol 24, Iss 1, Pp 1-11 (2024)

Abstract Background Positron emission tomography/computed tomography (PET/CT) using prostate-specific membrane antigen (PSMA)-targeted radiotracers labeled with zirconium-89 (89Zr; half-life ~ 78.41 h) showed promise in localizing biochemical recurre

Externí odkaz: https://doaj.org/article/03c17f9cf9d84758a0e74cfd128f0a03

Zobrazit plný text záznamu

Akademický článek

Dual FDG/PSMA PET imaging to predict lesion-based progression of mCRPC during PSMA-RLT

Autor: Florian Rosar, Caroline Burgard, Scott David, Robert J. Marlowe, Mark Bartholomä, Stephan Maus, Sven Petto, Fadi Khreish, Andrea Schaefer-Schuler, Samer Ezziddin

Publikováno v: Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)

Abstract Candidates for prostate-specific membrane antigen (PSMA)-targeted radioligand therapy (RLT) of metastatic castration-resistant prostate cancer (mCRPC) frequently have “mismatch” lesions with pronounced 18-fluorodeoxyglucose ([18F]FDG) bu

Externí odkaz: https://doaj.org/article/f9053057e4e4460dbb99f656e62bc2b4

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

[89Zr]Zr-PSMA-617 PET/CT characterization of indeterminate [68Ga]Ga-PSMA-11 PET/CT findings in patients with biochemical recurrence of prostate cancer: lesion-based analysis

Autor: Florian Rosar, Caroline Burgard, Elena Larsen, Fadi Khreish, Robert J. Marlowe, Andrea Schaefer-Schuler, Stephan Maus, Sven Petto, Mark Bartholomä, Samer Ezziddin

Publikováno v: Cancer Imaging, Vol 24, Iss 1, Pp 1-10 (2024)

Abstract Background The state-of-the-art method for imaging men with biochemical recurrence of prostate cancer (BCR) is prostate-specific membrane antigen (PSMA)-targeted positron emission tomography/computed tomography (PET/CT) with tracers containi

Externí odkaz: https://doaj.org/article/70e3e288133843f68a4f03ac95be4f7e

Zobrazit plný text záznamu

Akademický článek

Concomitant lithium increases radioiodine uptake and absorbed doses per administered activity in graves’ disease: comparison of conventional versus lithium-augmented radioiodine therapy

Autor: Fadi Khreish, Andrea Schaefer-Schuler, Leonie Roth, Caroline Burgard, Florian Rosar, Samer Ezziddin

Publikováno v: Frontiers in Medicine, Vol 11 (2024)

BackgroundLithium inhibits iodine and thyroid hormone release from thyroid cells, possibly increasing radioiodine retention and anti-hyperthyroid efficacy when given adjunctively to radioiodine therapy (RAI) of Graves’ disease (GD). However, the li

Externí odkaz: https://doaj.org/article/a3fddcb63ffb4e7db27a72e28f532edc

Zobrazit plný text záznamu

Akademický článek

Change of glucometabolic activity per PSMA expression predicts survival in mCRPC patients non-responding to PSMA radioligand therapy: introducing a novel dual imaging biomarker

Autor: Caroline Burgard, Jakob Engler, Arne Blickle, Mark Bartholomä, Stephan Maus, Andrea Schaefer-Schuler, Fadi Khreish, Samer Ezziddin, Florian Rosar

Publikováno v: Frontiers in Medicine, Vol 10 (2024)

PurposeThe value of [18F]fluorodeoxyglucose ([18F]FDG) PET/CT in monitoring prostate-specific membrane antigen (PSMA) targeted radioligand therapy (RLT) is still unclear. The aim of this study was to identify appropriate prognostic dynamic parameters

Externí odkaz: https://doaj.org/article/c1f82cdc6cb74ef7a564458e3ac9f5fa

Zobrazit plný text záznamu